Additional information was added to b5, h3, h4, h6 and h10.B5: the devices contained fluorouracil 3900 mg in 115 ml total volume in sodium chloride 0.9% bp.H4: device manufactured on april 22, 2023- april 25, 2023.H10: the actual devices were not available; however, photographs were provided for evaluation.A visual inspection was performed to the photographs using the naked eye which revealed fluid inside a yellow bag that contained the device; which suggested a leak occurred.The photos also showed white drug residue located at the connection of the blue winged luer cap which suggested a leak may have occurred at the connection of the blue winged luer cap.Due to the nature of the sample, no additional tests were performed.The reported condition was verified.The cause of the condition could not be determined from the photographs.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|